应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ALT Altimmune, Inc.
盘前交易 07-22 05:01:43 EDT
6.28
-0.27
-4.12%
盘前
6.45
+0.17
+2.71%
05:01 EDT
最高
6.63
最低
6.26
成交量
237.85万
今开
6.58
昨收
6.55
日振幅
5.73%
总市值
4.45亿
流通市值
4.42亿
总股本
7,090万
成交额
1,518万
换手率
3.38%
流通股本
7,039万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Altimmune, Inc.盘中异动 股价大跌5.07%报7.11美元
自选股智能写手 · 07-18
Altimmune, Inc.盘中异动 股价大跌5.07%报7.11美元
背景资料-减肥药开发商排队开发价值 1500 亿美元的市场
Reuters · 07-17
背景资料-减肥药开发商排队开发价值 1500 亿美元的市场
Altimmune, Inc.盘中异动 快速下挫5.06%报7.69美元
自选股智能写手 · 07-17
Altimmune, Inc.盘中异动 快速下挫5.06%报7.69美元
BUZZ-辉瑞推进减肥药开发的举动拖累了一些药品开发商
Reuters · 07-11
BUZZ-辉瑞推进减肥药开发的举动拖累了一些药品开发商
BUZZ-辉瑞推进减肥药的举措拖累了一些开发商
Reuters · 07-11
BUZZ-辉瑞推进减肥药的举措拖累了一些开发商
Altimmune, Inc.盘中异动 股价大涨5.06%报7.25美元
自选股智能写手 · 07-11
Altimmune, Inc.盘中异动 股价大涨5.06%报7.25美元
Altimmune, Inc.盘中异动 早盘股价大涨5.14%
自选股智能写手 · 07-08
Altimmune, Inc.盘中异动 早盘股价大涨5.14%
Altimmune, Inc.盘中异动 下午盘大幅下挫5.00%
自选股智能写手 · 07-03
Altimmune, Inc.盘中异动 下午盘大幅下挫5.00%
Altimmune, Inc.盘中异动 早盘股价大涨5.11%报6.99美元
自选股智能写手 · 07-01
Altimmune, Inc.盘中异动 早盘股价大涨5.11%报6.99美元
Altimmune, Inc.盘中异动 快速拉升5.02%
自选股智能写手 · 06-27
Altimmune, Inc.盘中异动 快速拉升5.02%
BUZZ--美国股票走势-Altimmune、通用磨坊、惠而浦
Reuters · 06-27
BUZZ--美国股票走势-Altimmune、通用磨坊、惠而浦
BUZZ--美国股票走势-Altimmune、通用磨坊、惠而浦
Reuters · 06-27
BUZZ--美国股票走势-Altimmune、通用磨坊、惠而浦
BUZZ--美国股票走势-Grindr、联邦快递、莫德纳
Reuters · 06-27
BUZZ--美国股票走势-Grindr、联邦快递、莫德纳
BUZZ-Altimmune 宣布首席财务官去世后股价下跌
Reuters · 06-26
BUZZ-Altimmune 宣布首席财务官去世后股价下跌
Altimmune, Inc.盘中异动 早盘股价大跌5.13%
自选股智能写手 · 06-26
Altimmune, Inc.盘中异动 早盘股价大跌5.13%
Altimmune, Inc.盘中异动 股价大跌5.01%报6.78美元
自选股智能写手 · 06-25
Altimmune, Inc.盘中异动 股价大跌5.01%报6.78美元
Altimmune, Inc.盘中异动 大幅上涨15.21%报7.39美元
自选股智能写手 · 06-24
Altimmune, Inc.盘中异动 大幅上涨15.21%报7.39美元
Altimmune, Inc.盘中异动 早盘股价大涨5.05%报6.24美元
自选股智能写手 · 06-21
Altimmune, Inc.盘中异动 早盘股价大涨5.05%报6.24美元
Altimmune, Inc.盘中异动 早盘股价大跌5.04%
自选股智能写手 · 06-14
Altimmune, Inc.盘中异动 早盘股价大跌5.04%
Altimmune, Inc.盘中异动 临近收盘股价大涨5.11%
自选股智能写手 · 06-12
Altimmune, Inc.盘中异动 临近收盘股价大涨5.11%
加载更多
公司概况
公司名称:
Altimmune, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Altimmune, Inc.于2005年4月25日根据特拉华州法律成立。Altimmune, Inc.是一家临床阶段的生物制药公司,专注于开发肥胖和肝病的治疗方法。他们的主要候选产品pemvidutide(以前称为ALT-801)是一种GLP-1/胰高血糖素双受体激动剂,正在开发用于治疗肥胖和代谢功能障碍相关的脂肪性肝炎(“MASH”),以前称为非酒精性脂肪性肝炎。
发行价格:
--
{"stockData":{"symbol":"ALT","market":"US","secType":"STK","nameCN":"Altimmune, Inc.","latestPrice":6.28,"timestamp":1721419200000,"preClose":6.55,"halted":0,"volume":2378505,"hourTrading":{"tag":"盘前","latestPrice":6.45,"preClose":6.28,"latestTime":"05:01 EDT","volume":48,"amount":306,"timestamp":1721638888304},"delay":0,"floatShares":70386824,"shares":70902191,"eps":-1.588042,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.27,"latestTime":"07-22 05:01:43 EDT","open":6.58,"high":6.63,"low":6.255,"amount":15175492.203824999,"amplitude":0.057252,"askPrice":7.58,"askSize":100,"bidPrice":5.68,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.588042,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"adjPreClose":6.28,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":6.45,"preClose":6.28,"latestTime":"05:01 EDT","volume":48,"amount":306,"timestamp":1721638888304},"postHourTrading":{"tag":"盘后","latestPrice":6.31,"preClose":6.28,"latestTime":"19:57 EDT","volume":38133,"amount":240794.7615,"timestamp":1721433478006},"volumeRatio":0.8370323135005684,"impliedVol":0.9514,"impliedVolPercentile":0.14},"requestUrl":"/m/hq/s/ALT","defaultTab":"news","newsList":[{"id":"2452333474","title":"Altimmune, Inc.盘中异动 股价大跌5.07%报7.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452333474","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452333474?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:00","pubTimestamp":1721314849,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时00分,Altimmune, Inc.股票出现波动,股价大幅下挫5.07%。截至发稿,该股报7.11美元/股,成交量71.3717万股,换手率1.01%,振幅5.87%。Altimmune, Inc.股票所在的生物技术行业中,整体跌幅为0.72%。其相关个股中,Onconetix, Inc.、Silo Pharma, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大,Silo Pharma, Inc.、Onconetix, Inc.、Salarius Pharmaceuticals, Inc.较为活跃,换手率分别为2037.03%、1075.31%、160.90%,振幅较大的相关个股有Silo Pharma, Inc.、Onconetix, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ,振幅分别为93.33%、86.24%、65.64%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718230049941f85c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718230049941f85c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4139","ALT"],"gpt_icon":0},{"id":"2452071163","title":"背景资料-减肥药开发商排队开发价值 1500 亿美元的市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2452071163","media":"Reuters","labels":["Product Release"],"top":-1,"share":"https://www.laohu8.com/m/news/2452071163?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:51","pubTimestamp":1721227909,"startTime":"0","endTime":"0","summary":"Wegovy与诺和诺德的糖尿病药物Ozempic使用相同的活性成分,于2021年获得批准。该公司报告说,在12月Zepbound上市的头几周, ,销售额达1.758亿美元。根据这项研究的数据,经过13周的治疗,VK2735帮助患者实现了高达14.7%的平均体重减轻。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU1623119135.USD","LU1894683348.USD","LU1069344957.HKD","NVO","LU0256863811.USD","IE00BKVL7J92.USD","ALT","GPCR","LU0096364046.USD","BK4532","BK4592","IE00BJJMRZ35.SGD","LU0820561818.USD","LU0466842654.USD","LU1551013425.SGD","LU1894683264.USD","SG9999001176.SGD","LU0321505868.SGD","LU0471298694.HKD","SG9999003800.SGD","LU0385154629.USD","LU0097036916.USD","LU1066051498.USD","IE0002141913.USD","BK4588","BK4581","LU1804176565.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","LU1712237335.SGD","LU2112291526.USD","LU0943347566.SGD","LU1878469433.USD","IE00BJLML261.HKD","OPK","LU1061106388.HKD","PFE","LU2242652126.USD","GB00BDT5M118.USD","IE0009355771.USD","LU0114720955.EUR","SG9999011175.SGD","LU0079474960.USD","AMGN","LU0882574055.USD","LU0882574139.USD","LLY","IE0004445239.USD","LU0109394709.USD"],"gpt_icon":1},{"id":"2452522161","title":"Altimmune, Inc.盘中异动 快速下挫5.06%报7.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452522161","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452522161?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:30","pubTimestamp":1721223051,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时30分,Altimmune, Inc.股票出现波动,股价快速下挫5.06%。截至发稿,该股报7.69美元/股,成交量9.6631万股,换手率0.14%,振幅0.25%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.涨幅较大,Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.较为活跃,换手率分别为616.34%、454.78%、91.01%,振幅较大的相关个股有Aditxt, Inc.、Terns Pharmaceuticals, Inc.、Kazia Therapeutics Limited,振幅分别为6.88%、6.34%、4.37%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172130519681da52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172130519681da52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1878469433.USD","ALT"],"gpt_icon":0},{"id":"2450357518","title":"BUZZ-辉瑞推进减肥药开发的举动拖累了一些药品开发商","url":"https://stock-news.laohu8.com/highlight/detail?id=2450357518","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450357518?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:07","pubTimestamp":1720703263,"startTime":"0","endTime":"0","summary":" (更新) 7月11日 - ** 减肥药开发商Viking Therapeutics 股价盘前下跌4.3%至55.50美元** 辉瑞 计划在今年下半年将其实验性肥胖药danuglipron的改良版、每日一次版推进到临床试验中。** 丹麦公司 Zealand Pharma A/S 下跌 4.5% ** 基于其减肥药物在 早期的积极数据,Zealand 预计将在 2024 年下半年启动一项中期试验** Altimmune 和Structure Therapeutics 的股价在收盘前小幅下跌** ALT和GPCR的肥胖症实验药物均已成功完成 中期试验 ** 截至上次收盘,VKTX的股价上涨了两倍多,ZELA上涨了一倍多,ALT下跌了33.5%,GPCR上涨了2.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","LU0868494617.USD","VKTX","BK4585","LU1066053197.SGD","SGXZ57979304.SGD","BK4007","BUZZ","BK4533","IE00B19Z3B42.SGD","LU0122379950.USD","IE00BLSP4239.USD","BK4534","BK4568","BK4588","IE00BBT3K403.USD","LU1894683348.USD","SG9999001176.SGD","IE00B19Z3581.USD","IE0002270589.USD","LU1883839398.USD","LU1878469433.USD","IE00BLSP4452.SGD","LU0456855351.SGD","LU0170899867.USD","ALT","BK4592","SG9999011175.SGD","LU0321505868.SGD","LU1066051498.USD","LU1023059063.AUD","PFE","BK4550","LU0289739699.SGD","SG9999003800.SGD","LU0058720904.USD","LU0234572021.USD","LU0321505439.SGD","SG9999001176.USD","BK4581","LU1894683264.USD","LU1057294990.SGD","SG9999002224.SGD","SG9999013999.USD","BK4139","SG9999002232.USD"],"gpt_icon":0},{"id":"2450726359","title":"BUZZ-辉瑞推进减肥药的举措拖累了一些开发商","url":"https://stock-news.laohu8.com/highlight/detail?id=2450726359","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450726359?lang=zh_cn&edition=full","pubTime":"2024-07-11 20:15","pubTimestamp":1720700140,"startTime":"0","endTime":"0","summary":" (更新) 7月11日 - ** 减肥药开发商Viking Therapeutics 股价盘前下跌4.8%至55.22美元** 辉瑞 计划在今年下半年将其实验性肥胖药danuglipron的改良版、每日一次版推进到临床试验中。** 今年 3 月,VKTX 公司称,其实验性口服药物 在一项小型早期试验中对志愿者进行了测试,结果显示其体重降低了 3.3%。** ALT 和 GPCR 的肥胖症实验药物均已成功完成 中期试验 ** 截至上次收盘,VKTX 的股价上涨了两倍多,ALT 下跌了 33.5%,GPCR 则上涨了 2.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4139","LU1894683348.USD","SG9999002224.SGD","BK4568","LU0122379950.USD","LU0234572021.USD","IE00BLSP4452.SGD","ALT","GPCR","IE00BBT3K403.USD","BK4592","LU1894683264.USD","SG9999001176.SGD","LU0321505439.SGD","LU0321505868.SGD","SG9999003800.SGD","SG9999002232.USD","LU1066051498.USD","VKTX","LU0289739699.SGD","BUZZ","BK4588","BK4581","LU0868494617.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","BK4533","SG9999001176.USD","LU1023059063.AUD","PFE","IE0002270589.USD","SG9999013999.USD","BK4585","LU1883839398.USD","SGXZ57979304.SGD","LU0456855351.SGD","LU1057294990.SGD","BK4550","IE00B19Z3581.USD","SG9999011175.SGD","BK4007","LU0058720904.USD","LU1878469433.USD","LU0170899867.USD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2450484343","title":"Altimmune, Inc.盘中异动 股价大涨5.06%报7.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450484343","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450484343?lang=zh_cn&edition=full","pubTime":"2024-07-11 01:04","pubTimestamp":1720631047,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日01时04分,Altimmune, Inc.股票出现异动,股价大幅上涨5.06%。截至发稿,该股报7.25美元/股,成交量124.988万股,换手率1.76%,振幅6.75%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为1.38%。其相关个股中,Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Longeveron Inc.涨幅较大,Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Kazia Therapeutics Limited较为活跃,换手率分别为3970.51%、1473.62%、1172.54%,振幅较大的相关个股有Kazia Therapeutics Limited、Revolution Medicines Inc C/Wts 17/12/2026 、Virpax Pharmaceuticals, Inc.,振幅分别为421.88%、133.16%、119.83%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711010407aef9020c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711010407aef9020c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","BK4139","LU1878469433.USD"],"gpt_icon":0},{"id":"2449970519","title":"Altimmune, Inc.盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449970519","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449970519?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:38","pubTimestamp":1720445896,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时38分,Altimmune, Inc.股票出现波动,股价快速上涨5.14%。截至发稿,该股报6.96美元/股,成交量26.9893万股,换手率0.38%,振幅2.95%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。其相关个股中,Morphic Holding, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Kineta, Inc.涨幅较大,Cero Therapeutics Holdings, Inc.、Kineta, Inc.、Scisparc Ltd.较为活跃,换手率分别为142.05%、110.57%、29.67%,振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Cero Therapeutics Holdings, Inc.、Anew Medical Inc C/Wts 21/06/2029 ,振幅分别为32.66%、27.47%、27.01%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213816941f4ec4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213816941f4ec4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1878469433.USD","ALT"],"gpt_icon":0},{"id":"2448160839","title":"Altimmune, Inc.盘中异动 下午盘大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448160839","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448160839?lang=zh_cn&edition=full","pubTime":"2024-07-03 01:44","pubTimestamp":1719942286,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日01时44分,Altimmune, Inc.股票出现异动,股价大幅跳水5.00%。截至发稿,该股报6.84美元/股,成交量224.465万股,换手率3.17%,振幅8.61%。Altimmune, Inc.股票所在的生物技术行业中,整体跌幅为1.07%。其相关个股中,Annovis Bio, Inc.、Zura Bio Limited C/Wts 、Newamsterdam Pharma Co Nv C/Wts 涨幅较大,Annovis Bio, Inc.、Geovax Labs, Inc.、Mustang Bio, Inc.较为活跃,换手率分别为209.76%、66.48%、61.61%,振幅较大的相关个股有Annovis Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 ,振幅分别为151.42%、72.83%、53.12%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703014446941f32ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703014446941f32ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4139","ALT"],"gpt_icon":0},{"id":"2448913109","title":"Altimmune, Inc.盘中异动 早盘股价大涨5.11%报6.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448913109","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448913109?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:37","pubTimestamp":1719841057,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时37分,Altimmune, Inc.股票出现异动,股价大幅上涨5.11%。截至发稿,该股报6.99美元/股,成交量28.1065万股,换手率0.40%,振幅4.51%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213738941f2bda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213738941f2bda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1878469433.USD","ALT"],"gpt_icon":0},{"id":"2446556474","title":"Altimmune, Inc.盘中异动 快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446556474","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446556474?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:26","pubTimestamp":1719498362,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日22时26分,Altimmune, Inc.股票出现异动,股价快速拉升5.02%。截至发稿,该股报6.57美元/股,成交量132.417万股,换手率1.87%,振幅6.24%。Altimmune, Inc.股票所在的生物技术行业中,整体跌幅为0.31%。其相关个股中,Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.涨幅较大,Geovax Labs, Inc.、Kala Bio, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为1586.55%、252.59%、241.72%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.,振幅分别为294.39%、127.05%、79.30%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627222602af8f8b88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627222602af8f8b88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1878469433.USD","ALT"],"gpt_icon":0},{"id":"2446311280","title":"BUZZ--美国股票走势-Altimmune、通用磨坊、惠而浦","url":"https://stock-news.laohu8.com/highlight/detail?id=2446311280","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446311280?lang=zh_cn&edition=full","pubTime":"2024-06-27 01:54","pubTimestamp":1719424491,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 6月26日 - 周三,华尔街主要股指在波澜不惊的交易中持平或走高,科技股在近期大跌后试图寻找底线,而投资者则在等待本周一份至关重要的通胀报告,以判断货币政策的走向。美东时间13:36,道琼斯工业平均指数 上涨0.09%,报39,147.45点。标普500指数 下跌0.06%,报5466.18点;纳斯达克综合指数 上涨0.19%,报17751.024点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RIVN","GIS","MU","SVRA","TQQQ","DOG","FDX","ALT","MRNA","DDOG","NQmain","GRND","NOC","LEVI","VSTO","SEDG",".DJI","LUV","SIX","APTV","QID","AVAV","AAPL","CNH",".IXIC","ALB","SDOW","TSLA","FFIE","QLD","ACN","UNF","WHR","WBA","MDB","DASH","AMZN","DJX","BUZZ","RPD","DDM","FUN","CMG","TSHA","CAT","QQQ","PB","MDT","UDOW"],"gpt_icon":1},{"id":"2446282311","title":"BUZZ--美国股票走势-Altimmune、通用磨坊、惠而浦","url":"https://stock-news.laohu8.com/highlight/detail?id=2446282311","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446282311?lang=zh_cn&edition=full","pubTime":"2024-06-27 01:54","pubTimestamp":1719424491,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 6月26日 - 周三,华尔街主要股指在波澜不惊的交易中持平或走高,科技股在近期大跌后试图寻找底线,而投资者则在等待本周一份至关重要的通胀报告,以判断货币政策的走向。美东时间13:36,道琼斯工业平均指数 上涨0.09%,报39,147.45点。标普500指数 下跌0.06%,报5466.18点;纳斯达克综合指数 上涨0.19%,报17751.024点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA","BUZZ","DDOG","LUV","CMG","NQmain","GRND",".DJI","DDM","MU","UNF","NOC","WBA","SEDG","WHR","CAT","FUN","FDX","DASH","SDOW","TSLA","QQQ","SIX","DOG","ALB","LEVI","APTV","CNH","GIS","QLD","UDOW","MDT","RPD","DJX","FFIE","MRNA","AAPL","QID","RIVN","AMZN","TQQQ","PB","AVAV","ALT","VSTO","MDB",".IXIC","SVRA","ACN"],"gpt_icon":0},{"id":"2446313446","title":"BUZZ--美国股票走势-Grindr、联邦快递、莫德纳","url":"https://stock-news.laohu8.com/highlight/detail?id=2446313446","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446313446?lang=zh_cn&edition=full","pubTime":"2024-06-27 00:17","pubTimestamp":1719418661,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 6月26日 - 华尔街主要股指周三涨跌不一,科技股在近期大跌后试图寻找下限,而投资者则在等待本周一份至关重要的通胀报告,以判断货币政策的走向。美东时间12:00,道琼斯工业平均指数 上涨0.07%,报39,139.7点。标普500指数 上涨0.07%,报5473.35点;纳斯达克综合指数 上涨0.39%,报17786.422点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RIVN","X","BK4124","MRNA","WBA","WHR","QLD","GRND","NOC","SQQQ","APTV","HD","QQQ","SIX","SEDG","ACN","BUZZ","LUV","FFIE",".DJI","DOG","GIS","FUN","DXD","MDT","SDOW","VSTO","SVRA","BA","NQmain","DDM","AAPL","UNF","DASH","TQQQ","DJX",".SPX","UDOW","GRND.WS","TSHA","TSLA","ALT","ALB","PSQ",".IXIC","LU0320765489.SGD","CMG","MNQmain","QID","FDX"],"gpt_icon":0},{"id":"2446397320","title":"BUZZ-Altimmune 宣布首席财务官去世后股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2446397320","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446397320?lang=zh_cn&edition=full","pubTime":"2024-06-26 23:02","pubTimestamp":1719414135,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 6月26日 - ** 药物开发商Altimmune 股价下跌超过10%,至6.70美元** ALT 周三宣布 (link),首席财务官 Richard Eisenstadt 于周一去世。** 公司任命Andrew Shutterly为代理首席财务官** 包括本交易日的跌幅在内,公司股价今年累计下跌超过 40","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","ALT","BK4139","LU1878469433.USD"],"gpt_icon":0},{"id":"2446968803","title":"Altimmune, Inc.盘中异动 早盘股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446968803","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446968803?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:35","pubTimestamp":1719408940,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时35分,Altimmune, Inc.股票出现波动,股价快速跳水5.13%。截至发稿,该股报7.03美元/股,成交量27.9719万股,换手率0.39%,振幅3.51%。Altimmune, Inc.股票所在的生物技术行业中,整体跌幅为0.52%。其相关个股中,Anew Medical, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Neurobo Pharmaceuticals, Inc.涨幅较大,Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃,换手率分别为327.33%、70.37%、65.94%,振幅较大的相关个股有Anew Medical, Inc.、Io Biotech, Inc.、Atossa Therapeutics, Inc.,振幅分别为40.61%、25.20%、20.87%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626213541aef6be68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626213541aef6be68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4139","ALT"],"gpt_icon":0},{"id":"2446390841","title":"Altimmune, Inc.盘中异动 股价大跌5.01%报6.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446390841","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446390841?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:31","pubTimestamp":1719322294,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时31分,Altimmune, Inc.股票出现异动,股价快速跳水5.01%。截至发稿,该股报6.78美元/股,成交量29.7982万股,换手率0.42%,振幅4.06%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.64%。其相关个股中,Glycomimetics, Inc.、Senti Biosciences, Inc.、Anew Medical, Inc.涨幅较大,Effector Therapeutics, Inc.、Glycomimetics, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为84.96%、78.39%、56.72%,振幅较大的相关个股有Glycomimetics, Inc.、Lipella Pharmaceuticals Inc.、Geovax Labs, Inc.,振幅分别为12.94%、12.48%、9.92%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521313496816a0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062521313496816a0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1878469433.USD","ALT"],"gpt_icon":0},{"id":"2445271074","title":"Altimmune, Inc.盘中异动 大幅上涨15.21%报7.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445271074","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445271074?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:31","pubTimestamp":1719235874,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时31分,Altimmune, Inc.股票出现异动,股价大幅上涨15.21%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.89%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。消息层面,截至21时31分,《派杰投资维持Altimmune买入评级,维持目标价25美元》资讯为影响Altimmune, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062421311495d2b4af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062421311495d2b4af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","ALT","BK4139"],"gpt_icon":0},{"id":"2445500387","title":"Altimmune, Inc.盘中异动 早盘股价大涨5.05%报6.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445500387","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445500387?lang=zh_cn&edition=full","pubTime":"2024-06-21 21:42","pubTimestamp":1718977378,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日21时42分,Altimmune, Inc.股票出现波动,股价大幅拉升5.05%。截至发稿,该股报6.24美元/股,成交量25.0134万股,换手率0.35%,振幅4.04%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.45%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。消息层面,截至21时42分,《派杰投资维持Altimmune买入评级,维持目标价25美元》资讯为影响Altimmune, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062121425996815c99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062121425996815c99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4139","ALT"],"gpt_icon":0},{"id":"2443679086","title":"Altimmune, Inc.盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443679086","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443679086?lang=zh_cn&edition=full","pubTime":"2024-06-14 22:37","pubTimestamp":1718375823,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日22时37分,Altimmune, Inc.股票出现波动,股价快速下跌5.04%。截至发稿,该股报6.28美元/股,成交量44.8845万股,换手率0.63%,振幅3.93%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.08%。其相关个股中,Cns Pharmaceuticals, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Longeveron Inc.、Cns Pharmaceuticals, Inc.、Bio-Path Holdings, Inc.较为活跃,换手率分别为885.16%、437.02%、205.95%,振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nkgen Biotech Inc C/Wts 31/05/2028,振幅分别为118.78%、57.51%、54.75%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614223704941eeaf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614223704941eeaf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1878469433.USD","ALT"],"gpt_icon":0},{"id":"2442349034","title":"Altimmune, Inc.盘中异动 临近收盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442349034","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442349034?lang=zh_cn&edition=full","pubTime":"2024-06-12 03:52","pubTimestamp":1718135567,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日03时52分,Altimmune, Inc.股票出现异动,股价大幅拉升5.11%。截至发稿,该股报6.58美元/股,成交量152.545万股,换手率2.15%,振幅8.62%。Altimmune, Inc.股票所在的生物技术行业中,整体跌幅为0.40%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612035247af8cf8be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612035247af8cf8be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4139","ALT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.altimmune.com","stockEarnings":[{"period":"1week","weight":-0.2051},{"period":"1month","weight":0.0626},{"period":"3month","weight":-0.0912},{"period":"6month","weight":-0.3211},{"period":"1year","weight":0.9748},{"period":"ytd","weight":-0.4418}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Altimmune, Inc.于2005年4月25日根据特拉华州法律成立。Altimmune, Inc.是一家临床阶段的生物制药公司,专注于开发肥胖和肝病的治疗方法。他们的主要候选产品pemvidutide(以前称为ALT-801)是一种GLP-1/胰高血糖素双受体激动剂,正在开发用于治疗肥胖和代谢功能障碍相关的脂肪性肝炎(“MASH”),以前称为非酒精性脂肪性肝炎。","yearOnYearQuotes":[{"month":1,"riseRate":0.411765,"avgChangeRate":-0.003942},{"month":2,"riseRate":0.352941,"avgChangeRate":-0.000026},{"month":3,"riseRate":0.411765,"avgChangeRate":-0.040906},{"month":4,"riseRate":0.352941,"avgChangeRate":-0.055497},{"month":5,"riseRate":0.470588,"avgChangeRate":0.065968},{"month":6,"riseRate":0.411765,"avgChangeRate":0.016734},{"month":7,"riseRate":0.411765,"avgChangeRate":0.046343},{"month":8,"riseRate":0.375,"avgChangeRate":0.111412},{"month":9,"riseRate":0.235294,"avgChangeRate":-0.12361},{"month":10,"riseRate":0.176471,"avgChangeRate":0.026317},{"month":11,"riseRate":0.352941,"avgChangeRate":-0.04187},{"month":12,"riseRate":0.588235,"avgChangeRate":0.233742}],"exchange":"NASDAQ","name":"Altimmune, Inc.","nameEN":"Altimmune, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Altimmune, Inc.,ALT,Altimmune, Inc.股票,Altimmune, Inc.股票老虎,Altimmune, Inc.股票老虎国际,Altimmune, Inc.行情,Altimmune, Inc.股票行情,Altimmune, Inc.股价,Altimmune, Inc.股市,Altimmune, Inc.股票价格,Altimmune, Inc.股票交易,Altimmune, Inc.股票购买,Altimmune, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}